About Oxford Science Enterprises
Oxford Science Enterprises is a venture capital firm founded in 2015. It is primarily based out of Oxford, United Kingdom. As of Apr 2026, Oxford Science Enterprises is an active investor, having invested in 112 companies, with 7 new investments in the last 12 months. It primarily invests in Series A round in United Kingdom based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Enterprise Applications. Most recently it participated in the $***** Seed round of Ascension Overall, Oxford Science Enterprises portfolio has seen 3 IPOs and 14 acquisitions including key companies like Oxford Ionics, Barinthus Biotherapeutics and Pepgen. A lot of funds co-invest with Oxford Science Enterprises, with names like Oxford Investment Consultants sharing a substantial percentage of its portfolio. Oxford Science Enterprises has team of 58 people including 11 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Series A & 2 more
Portfolio IPOs
Portfolio Acquisitions
Portfolio Soonicorns
Deals in last 12 months
Oxford Science Enterprises' List of Top Investments
Oxford Science Enterprises has a portfolio of 112 companies. Their most notable investments are in Orbit Discovery and Base Genomics.Their portfolio spans across United Kingdom, United States, Canada and 3 more locations. They have invested in Life Sciences, High Tech, Enterprise Applications and 25 other sectors, across stages such as Seed, Series A and 2 more. Here is the list of top investments by Oxford Science Enterprises:1. BibliU
Provider of digital learning content and campus store management solutions. The platform offers institutions tools to automate content workflows and improve learning outcomes. It provides digital textbooks, monographs, and courseware. The platform integrates with existing systems to deliver an interactive learning experience. It supports diverse academic needs of students and faculty.
Key facts about BibliU
- Founded Year: 2014
- Location: Greenville (United States)
- Annual Revenue: £55.2M as on Oct 31, 2024
- Stage: Series B
- Total Funding till date: $47.4M
- Employee Count: 171 as on Mar 31, 2026
- Investors: Oxford University Innovation, SFC Capital and 25 Others
- Latest Funding Round: Series B, Sep 28, 2022, $*****
- Highlight: Editors' Pick
2. Perspectum
Provider of AI-powered medical imaging and precision diagnostics software. It t use AI and MRI-based analytics to help clinicians assess organ health, support diagnosis, and monitor disease progression. It delivers cloud-based diagnostic reporting and imaging biomarkers for healthcare providers, clinical trials, and research use cases.
Key facts about Perspectum
- Founded Year: 2012
- Location: Oxford (United Kingdom)
- Stage: Series C
- Total Funding till date: $140M
- Employee Count: 263 as on Mar 31, 2026
- Investors: Health Quest Capital, Oppenheimer and 30 Others
- Latest Funding Round: Series C, Mar 15, 2023, $*****
- Highlight: Editors' Pick
Provider of quantum computers. It provides users with superconducting qubits as their physical support for Universal Quantum computers. It offers quantum computers by combining the qubits and trapped ions by using noiseless electronic qubit control technology.
Key facts about Oxford Ionics
- Founded Year: 2019
- Location: Oxford (United Kingdom)
- Stage: Acquired
- Total Funding till date: $48.4M
- Employee Count: 98 as on Mar 31, 2026
- Investors: Prosus, Oxford University Innovation and 9 Others
- Latest Funding Round: Series A, Aug 31, 2023, $*****
- Highlight: Acquired
Developer of a quantum computer based on superconducting qubits. It aims to develop a quantum computer based on superconducting qubits. Its features include a functional unit, a control system, and quantum hardware and software.
Key facts about Quantum Circuits Limited
- Founded Year: 2007
- Location: Reading (United Kingdom)
- Valuation: $*****
- Stage: Series A
- Total Funding till date: $50.2M
- Employee Count: 143 as on Feb 28, 2026
- Investors: Oxford University Innovation, University of Oxford and 10 Others
- Latest Funding Round: Series A, Feb 03, 2023, $*****
- Highlight: Editors' Pick
Developer of T-cell immunotherapeutics to treat multiple diseases. The company has proprietary platform technologies ChAdOx, MVA, SNAP-TI, and SNAP-CI to develop pipeline of product candidates across a diverse range of therapeutic areas including chronic infectious diseases, autoimmunity, and cancer.
Key facts about Barinthus Biotherapeutics
- Founded Year: 2016
- Location: Germantown (United States)
- Annual Revenue: $15M as on Dec 31, 2024
- Stage: Public
- Total Funding till date: $210M
- Employee Count: 36 as on Mar 31, 2026
- Investors: HTIF, Gilead and 11 Others
- Latest Funding Round: Post IPO, Dec 25, 2023, $*****
- Highlight: Public
Oxford Science Enterprises' Year-on-Year Investment Trends
Oxford Science Enterprises has invested in 112 companies over the last 11 years, with an average of 8 new investments annually in the last 10 years. In 2025, it made 11 investments, while as of Apr 2026, it has made 4 investments in this year. Its most recent first time investment was in Ascension and most recent follow-on round was in Archangel Lightworks.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 2 | 2 | 4 |
2025 | 8 | 3 | 11 |
2024 | 3 | 8 | 11 |
2023 | 12 | 7 | 19 |
2022 | 9 | 10 | 19 |
2021 | 5 | 12 | 17 |
2020 | 11 | 7 | 18 |
2019 | 6 | 0 | 6 |
2018 | 10 | 7 | 17 |
2017 | 3 | 3 | 6 |
Oxford Science Enterprises' Investments by Stage
Oxford Science Enterprises has made 43 investments in Seed stage with an average round size of $4.86M, 28 investments in Series A stage with an average round size of $22.5M, 11 investments in Series B stage with an average round size of $40.5M and 1 investment in Series C stage with an average round size of $85M.Stage of entry | No. of Investments |
|---|---|
Seed | 43 |
Series A | 28 |
Series B | 11 |
Series C | 1 |
Note: We have considered here, only first round of investments
Oxford Science Enterprises' Investments by Sector
Oxford Science Enterprises has a diverse portfolio, with companies operating in the Life Sciences, High Tech, Enterprise Applications, HealthTech and Semiconductors. Notably, it has invested in 98 Tech companies, 96 Enterprise (B2B) companies, 37 Software companies and at least 37 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Life Sciences | 33 |
High Tech | 28 |
Enterprise Applications | 25 |
HealthTech | 16 |
Semiconductors | 8 |
Others | 66 |
Note: We have considered here, only first round of investments
Oxford Science Enterprises' Investments by Geography
Oxford Science Enterprises has made most investments in United Kingdom (70), followed by United States where it has made 9 investments.Country | No. of Investments |
|---|---|
United Kingdom | 70 |
United States | 9 |
Canada | 1 |
Finland | 1 |
Netherlands | 1 |
Note: We have considered here, only first round of investments
Oxford Science Enterprises' recent investments
Oxford Science Enterprises has made 4 investments in 2026 so far. Ascension and Archangel Lightworks are the latest among them.Here are the most recent investments by Oxford Science Enterprises:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Apr 15, 2026 | United Kingdom | Seed | 3893 | ||
Apr 14, 2026 | United Kingdom | Series A | 1060 | [+2] | |
Jan 12, 2026 | United States | Seed | 1218 | [+1] | |
Jan 08, 2026 | United States | Series C | 1818 | [+4] | |
Nov 12, 2025 | United Kingdom | Seed | 7360 |
IPOs and Publicly Listed companies in Oxford Science Enterprises' Portfolio
3 of Oxford Science Enterprises' portfolio companies have become public. Pepgen got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in May 2022 at marketcap of $269M and Barinthus Biotherapeutics got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $579M.Here are Oxford Science Enterprises' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
May 06, 2022 | Nov 24, 2020 | Series A | 1078 | |
Apr 30, 2021 | May 12, 2016 | Seed | 1033 | |
- | - | - | 6417 |
Acquired companies in Oxford Science Enterprises' Portfolio
14 companies from Oxford Science Enterprises' portfolio have been acquired. The most recent acquisition was Brill Power in Sep 2025 by Palmer Energy Technology for $*****.Here are Oxford Science Enterprises' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Sep 01, 2025 | Feb 17, 2021 | Seed | 2769 | |
Jun 09, 2025 | Jan 09, 2023 | Series A | 1321 | |
Feb 18, 2025 | - | - | 4354 | |
Jul 16, 2024 | Jun 06, 2019 | Series A | 2420 | |
Oct 20, 2022 | Dec 22, 2020 | Series A | 6285 |
Team profile of Oxford Science Enterprises
Oxford Science Enterprises has a team of 58 members including 11 Partners, 1 Venture Partner and 8 Principals located in United Kingdom, Netherlands and 1 more location. Oxford Science Enterprises' team sits on the board of 2 companies.Here is a list of top team members in Oxford Science Enterprises:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Brussels | - | - | |
Partner | London | - | ||
Partner | Utrecht | - | - | |
Partner | United Kingdom | - | - | |
Partner | Bristol | - | - | |
Partner | - | - | - | |
Partner | - | - | - | |
Partner | - | - | - | |
Partner | London | - | - |
Co-investors of Oxford Science Enterprises
Over the past 11 years, 361 investors have co-invested in Oxford Science Enterprises's portfolio companies. This includes funds and angels.
- Invested before Oxford Science Enterprises: Parkwalk, Europa and 52 others have invested in rounds before Oxford Science Enterprises. There are 9 companies where Parkwalk has invested before Oxford Science Enterprises and 5 companies where Europa has invested before Oxford Science Enterprises.
- Top Co-investors of Oxford Science Enterprises: 151 investors entered a company along with Oxford Science Enterprises. These include investors like Oxford Investment Consultants (6 companies).
- Invested after Oxford Science Enterprises: A total of 156 investors have invested in Oxford Science Enterprises's portfolio after their investments. Top Investors include University of Oxford (11 companies), Oxford University Innovation (5 companies) and Oxford Investment Consultants (5 companies).
Recent News related to Oxford Science Enterprises
•
Wild Bioscience Expands Milton Park Operations After £45 Million Series Aigrownews.com•Apr 23, 2026•wild bio, Oxford Science Enterprises, Braavos
•
Fractile in talks with Accel to raise $200M at $1B valuation as UK‑based NVIDIA alternativeTech Funding News•Mar 31, 2026•NIF, Fractile, Oxford Science Enterprises, Accel
•
•
•
Dwight Capital Provides $31M HUD Loan for Texas Apartments ConstructionCommercial Observer•Dec 17, 2025•Oxford Science Enterprises, Dwight Capital
•
UK's Scripta Therapeutics secures over €10 million to revolutionize drug discoveryEU-Startups•Nov 13, 2025•Oxford Science Enterprises, Apollo Health Ventures, Scripta Therapeutics, YZR Capital and 3 others
•
Valink Therapeutics Closes $11.8 Million Pre-A Financing Round to Advance Oncology Pipelineintelligence360•Nov 10, 2025•LongeVC, RV Invest, Valink Therapeutics, Oxford Science Enterprises and 2 others
•
Kneu Health Secures £4.2 Million Seed Funding to Accelerate AI-Powered Neurology PlatformGlobal Legal Chronicle•Nov 05, 2025•Marriottharrison, Oxford Science Enterprises, Kneu Health
•
Valink Therapeutics Closes $11.8 Million Pre-A Financing Round to Advance Oncology PipelineBusiness Wire•Oct 20, 2025•LongeVC, RV Invest, Valink Therapeutics, Oxford Science Enterprises and 3 others
•
Wild Bioscience secures €51 million to improve crop variety with AI and precision breedingEU-Startups•Oct 16, 2025•Eit, Oxford Science Enterprises, wild bio, University of Oxford and 2 others
